Actionnariat et activité des initiés pour Arcutis Biotherapeutics, Inc. (ARQT): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $26.14 |
| Capitalisation | $3.3B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-08 | Matsuda Masaru | S-Sale | 9,989 | $250K |
| 2026-08-27 | Curran Terrie | M-Exempt | 27,052 | $233K |
| 2026-08-27 | Curran Terrie | M-Exempt | 11,148 | $84K |
| 2026-08-27 | Curran Terrie | S-Sale | 27,052 | $677K |
| 2026-08-27 | Curran Terrie | M-Exempt | 27,052 | $233K |
| 2026-08-27 | Curran Terrie | M-Exempt | 11,148 | $84K |
| 2026-08-20 | Curran Terrie | M-Exempt | 1,072 | $8K |
| 2026-08-20 | Curran Terrie | S-Sale | 1,072 | $28K |
| 2026-08-20 | Curran Terrie | M-Exempt | 1,072 | $8K |
| 2026-08-19 | Burnett Patrick | S-Sale | 1,697 | $46K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $3.4M | $39.4M | $63.3M | $65.1M | $98.0M | $53.6M | $88.4M | $71.3M | $42.9M |
| Placements à Court Terme | 0 | $11.5M | $37.9M | $219.4M | $290.6M | $355.9M | $183.5M | $156.6M | $178.1M |
| Créances | 0 | 0 | 0 | $510000 | $362000 | $8.5M | $25.8M | $73.1M | $146.2M |
| Stocks | 0 | 0 | 0 | 0 | 0 | $7.5M | $13.1M | $14.5M | $22.6M |
| Actifs Courants | $3.8M | $51.1M | $106.5M | $292.8M | $402.8M | $437.4M | $330.4M | $335.8M | $411.2M |
| Immobilisations Corporelles | 0 | 0 | $491000 | $5.4M | $5.3M | $4.6M | $3.9M | $3.0M | $5.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | $7.2M | $6.4M | $9.5M | $14.8M |
| Actifs Totaux | $3.8M | $51.1M | $107.0M | $298.3M | $408.2M | $449.3M | $341.4M | $348.9M | $433.0M |
| Dettes Fournisseurs | $537000 | $1.8M | $1.4M | $7.1M | $7.4M | $8.8M | $12.0M | $14.2M | $12.5M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | $433000 | 0 | 0 | 0 | $1.0M |
| Passifs Courants | $692000 | $2.7M | $5.2M | $22.6M | $33.3M | $37.8M | $46.7M | $81.0M | $129.8M |
| Dette à Long Terme | $966000 | 0 | 0 | 0 | $72.3M | $197.8M | $201.8M | $107.2M | $5.3M |
| Passifs Totaux | $8.8M | $75.1M | $5.5M | $27.6M | $110.5M | $239.7M | $252.7M | $191.3M | $243.5M |
| Réserves | -$5.0M | -$24.3M | -$66.3M | -$201.9M | -$408.3M | -$719.8M | -$981.9M | -$1.12B | -$1.14B |
| Capitaux Propres | -$5.0M | -$24.0M | $101.5M | $270.6M | $297.7M | $209.6M | $88.7M | $157.5M | $189.5M |
| Dette Totale | $966000 | 0 | $307000 | $5.0M | $77.6M | $202.5M | $205.9M | $110.6M | $6.3M |
| Dette Nette | -$2.5M | -$50.9M | -$101.0M | -$279.5M | -$311.0M | -$207.0M | -$65.9M | -$117.4M | -$214.7M |
| Fonds de Roulement | $3.1M | $48.4M | $101.2M | $270.2M | $369.4M | $399.6M | $283.8M | $254.8M | $281.4M |
Santé financière
| Dette / Capitaux propres | 0.52 |
| Ratio de liquidité | 2.92 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 6.98 |
Rentabilité
| Rentabilité des capitaux propres | -8.52% |
| Rentabilité du capital investi | -4.02% |
| Rentabilité des actifs | -3.73% |
| Marge brute | 91.14% |
| Marge opérationnelle | 7.38% |
| Marge nette | 6.15% |
Entreprises liées: CELC · CGON · CNTA · FOLD · IRON · LEGN · TARS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ARQT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions